home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

Bispecifics In Discovery & Development Congress

  January 22, 2019  
Oxford Global, Maritim proArte Hotel, Berlin, Germany
11th - 12th June 2019

Over 18 presentations and case studies focusing on the latest trends and technologies in Bispecifics discovery as well as the considerations for immunogenicity, safety, CMC, biomarkers in bringing Bispecific in clinic. The congress also explores the role of Bispecific antibodies in paving the next wave of biotherapeutics.

View agenda: https://bit.ly/2VW3c1X

Organized by: Oxford Global
Invited Speakers:

 2019 Bispecific Congress Confirmed Speakers Include:

  • John Delaney, Executive Director, Research, Amgen
  • Antonio de Fougerolles, CEO, Evox Therapeutics
  • Christophe Blanchetot, Director Discovery, Argenx BVBA
  • Mark Throsby, CSO, Merus

For the full list of confirmed speakers, please see the agenda: https://bit.ly/2VW3c1X


Deadline for Abstracts: N/A


E-mail: g.alonso@oxfordglobal.co.uk
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.